ArticleFrontiers in oncology2019

MiR-199a Inhibits Tumor Growth and Attenuates Chemoresistance by Targeting K-RAS via AKT and ERK Signalings.

Wei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.